1.5 million people worldwide are losing their sight now due to Retinitis Pigmentosa. It is the leading cause of inherited blindness with the slow and progressive degeneration of photoreceptors in the retina.
Endogena therapeutics pioneering approach as the potential to change the degenerative condition such as retinitis pigmentosa patients are treated.
Endogena compounds EA-2353 reactivate the retinal stem cells in the ciliary epithelium around the iris. These actively differentiating cells migrate to the retina, where they mature into functional photoreceptors.
This retinal structure and function regeneration could potentially reverse the loss of vision for patients with retinitis pigmentosa regardless of the genetic trigger causing their disease.
More info
(info@endogena.com)
Explore more about Endogena Therapeutics
([ Ссылка ])
#EndogenaTherapeutics #RegenerativeMedicine #RetinitisPigmentosa #StemCell #Ophthalmology #Eyes #Vision #VisionLoss #Blindness
Ещё видео!